A Proteino(Path)y to a Cure: A membranic approach to Alzheimer’s Disease

When a dentist is faced with plaques, the knee-jolt response is to floss more frequently; unfortunately, there is no dental floss to clean out the folds of the brain. Alzheimer’s Disease (AD) is a proteinopathic disease, meaning it is characterized by the accumulation of misfolded proteins in the brain, such as amyloid-β, which forms microscopic plaques (Rukmangadachar and Bollu 2025). The neurotoxic Aβ peptide is produced within neurons and then secreted to the extracellular area, with amino acids 25-35 (Aβ25–35) being the primary neurotoxic domain (Chen et al. 2017; D’Ezio et al. 2021; Naderi et al. 2023). Aβ25–35 will also embed itself in the hydrophobic core of the phospholipid bilayer, as seen in Figure 1, where it disrupts homeostasis (Gastaldo et al. 2020).

Figure 1. The aggregation pathway of Aβ25–35 in the membrane. Insertion into the lipid membrane is not thermodynamically favourable, so it will enter and leave until aggregation can occur. Image credits to Gastaldo et al. 2020.

Due to size differences between Aβ25–35‘s hydrophobic domain and membrane width, there is a hydrophobic mismatch which causes membrane deformation (Khondker et al. 2018). This deformation protects hydrophobic domains from exposure, while increasing thermodynamic favourability of Aβ25–35 aggregation. In a 2D model, when a large aggregation and several small aggregations have the same area and shape, the large aggregation will always have a smaller circumference. As such, membrane deformation favours one large Aβ25–35 aggregation since it is more energy efficient, as seen in Equation 1.

Equation 1. Gibbs free energy of bulk energy gain and interface energy (energy to maintain a boundary), with radius (R), free energy per unit area (g0), and the line tension (σ). The bulk energy gain of the aggregate is negative since that is more spontaneous, and increases with area (R2). The interface energy is based on circumference (2πR), which is larger in several small aggregations versus one large one. Equation sourced from Khondker et al. 2018.

A stiffer and thicker membrane will have a higher line tension; a thicker, stiffer membrane requires more energy to deform, and thus will force a large aggregation, while a thin, flexible membrane has more leeway. Certain compounds, such as acetylsalicylic acid (ASA) and curcumin can alter membranic properties, altering σ and the formation of Aβ25–35 aggregations (Khondker et al. 2018). ASA increases σ, making it more favourable for a larger radius, and, thus, a larger aggregation, since that leads to a negative Gibbs Free Energy (spontaneous reaction) (Khondker et al. 2018). Curcumin, however, decreases σ, making it less favourable to form and maintain an aggregation (Khondker et al. 2018). Unfortunately, curcumin has a low bioavailability, which means very little of it makes it into the bloodstream to be delivered to the brain (Stępnik 2026). A good way to increase bioavailability is by increasing the surface area of a molecule, such as through delivery systems such as Multi-Walled Carbon Nanotubes (MWCNTs) (Nabitabar et al. 2024). This method was proven successful through Pawar and Suvarna, who designed curcumin-loaded MWCNTs which can be delivered nasally (2025).

These sorts of studies provide hope for the future of proteinopathy treatment. From Alzheimer’s, to Parkinson’s, to prion diseases like Creutzfeldt-Jakob disease, millions people across the world suffer from these protein-misfolding diseases. Furthering the knowledge about these diseases—and novel ways to treat them—is the best path towards a cure; after all, just as all roads lead to Rome, there are many paths to a solution in science.

References

Chen, Guo-fang, Ting-hai Xu, Yan Yan, et al. “Amyloid Beta: Structure, Biology and Structure-Based Therapeutic Development.” Acta Pharmacologica Sinica 38, no. 9 (2017): 1205–35. https://doi.org/10.1038/aps.2017.28.

D’Ezio, Veronica, Marco Colasanti, and Tiziana Persichini. “Amyloid-β 25-35 Induces Neurotoxicity through the Up-Regulation of Astrocytic System Xc−.” Antioxidants 10, no. 11 (2021): 1685. https://doi.org/10.3390/antiox10111685.

Gastaldo, Isabella P., Sebastian Himbert, Udbhav Ram, and Maikel C. Rheinstädter. “The Effects of Resveratrol, Caffeine, β-Carotene, and Epigallocatechin Gallate (EGCG) on Amyloid-Β25–35 Aggregation in Synthetic Brain Membranes.” Molecular Nutrition & Food Research 64, no. 22 (2020): 2000632. https://doi.org/10.1002/mnfr.202000632.

Khondker, Adree, Richard J. Alsop, Sebastian Himbert, et al. “Membrane-Modulating Drugs Can Affect the Size of Amyloid-Β25–35 Aggregates in Anionic Membranes.” Scientific Reports 8, no. 1 (2018): 12367. https://doi.org/10.1038/s41598-018-30431-8.

Nabitabar, Masoumeh, Maryam Shaterian, Hossein Danafar, and Morteza Enhessari. “Multi-Wall Carbon Nanotube Surface-Based Functional Nanoparticles for Stimuli-Responsive Dual Pharmaceutical Compound Delivery.” Scientific Reports 14, no. 1 (2024): 12073. https://doi.org/10.1038/s41598-024-59745-6.

Naderi, Soudabeh, Fariba Khodagholi, Hamid Gholami Pourbadie, et al. “Role of Amyloid Beta (25-35) Neurotoxicity in the Ferroptosis and Necroptosis as Modalities of Regulated Cell Death in Alzheimer’s Disease.” Neurotoxicology 94 (January 2023): 71–86. https://doi.org/10.1016/j.neuro.2022.11.003.

Pawar, Shrutee, and Vasanti Suvarna. “Curcumin-Loaded PEG-Functionalized Carbon Nanotubes: A Novel Strategy for Alzheimer’s Management.” Therapeutic Delivery 16, no. 8 (2025): 755–63. https://doi.org/10.1080/20415990.2025.2513213.

Rukmangadachar, Lokesh A., and Pradeep C. Bollu. “Amyloid Beta Peptide.” In StatPearls. StatPearls Publishing, 2025. http://www.ncbi.nlm.nih.gov/books/NBK459119/.

Stępnik, Katarzyna. “Curcumin in Alzheimer’s Disease: From Mechanistic Insights to Translational Challenges and Emerging Curcuminoid Strategies.” International Journal of Molecular Sciences 27, no. 13 (2026): 5754. https://doi.org/10.3390/ijms27135754.

Comments

8 Responses to “A Proteino(Path)y to a Cure: A membranic approach to Alzheimer’s Disease”

  1. Ethan Yoon Avatar
    Ethan Yoon

    Hey, Emily! Awesome work on your blog post – it was great to read about a potential cure for Alzheimer’s, which can affect so, so many people worldwide in such a positive manner. I just have a couple of comments:
    1. Make sure to post your comment!
    2. Paragraph 3, sentence 1: Consider un-repeating the “thicker, stiffer membrane”!
    3. Although you have defined sigma in your figure caption, consider re-defining it in your actual post, as readers who do not read the fig cap can get confused as to what the nature of that symbol actually is.

    That’s all! Once again, awesome job on your blog post, and I can’t wait to read the final version.

    – Ethan

  2. Winning Osemwengie Avatar
    Winning Osemwengie

    Hey Emily,

    Great blog post! It was rather insightful to read about the biochemical processes which give way to Alzheimer’s disease. Here are a few of my critiques:
    1. The hook implied that there would be further discussion or reference to the correlation between oral health and Alzheimer’s, it may be helpful the have a hook closer related to the subject matter of the text.
    2. The first sentence of your third paragraph “A stiffer and thicker membrane…” can be written more concisely to better convey its information.
    3. The sentences in the third body would benefit from more flow, such that the topic at hand is presented more effectively.
    Overall I found that you did a great job integrating the concepts of physics and math to discuss Alzheimer’s, a disease commonly analyzed through a biological context.
    Again, amazing work, I thoroughly enjoyed your topic matter and presentation.

    – Winning O.

  3. Grace Lorenz Avatar
    Grace Lorenz

    Hi Emily,

    This was a super interesting blog post! You explained the misfolded proteins associated with Alzheimer’s in a very clear way. My only suggestion is:
    -In P1S2, you introduce an abbreviation for Alzheimer’s (AD), but AD is not used again in the blog post. So, adding the abbreviation is unnecessary.

    Great job!
    Grace

  4. Nathaniel Wang Avatar
    Nathaniel Wang

    Hi Emily!

    Great job on the blog post, a very relevant topic to write about and I am always one to appreciate any humor in blogs and titles. A few small suggestions are:

    -P2S2: You mention that deformation protects hydrophobic domains from exposure. A small clarification of exposure to what (the surrounding aqueous/water environment) could make the biophysical reasoning clearer.

    P3S3: In the phrase “ASA increases sigma, making it more favourable for a larger radius, and, thus, a larger aggregation…”, consider changing the sentence for improved clarity to: “ASA increases sigma, making it more favourable for a larger radius, and thus a larger aggregation, since that leads to a negative Gibbs Free Energy (spontaneous reaction) (Khondker et al. 2018).”

    P4S2: Small typo in “millions people”. Change to “millions of people”

    Overall, great work on your post and I look forward to seeing the final! Happy editing

    Nathaniel Wang

  5. Gurdit Sra Avatar
    Gurdit Sra

    Hi Emily!

    Great post. The floss hook made me laugh, and you explained the Gibbs free energy part really clearly. Two small suggestions:

    -P1, S1: “Knee-jolt” should be “knee-jerk.”

    -P3, S6: “Proven successful” might be a bit strong. Pawar and Suvarna designed the curcumin-loaded nanotubes, but it’s still early research, so something like “showed promising results” might fit better.

    Overall, awesome job bringing physics and math into a bio topic. Looking forward to the final copy!

    Gurdit

  6. Emily Martin Avatar
    Emily Martin

    Hi iSci!

    I hope you all enjoyed my post on the membrane biophysics in Alzheimer’s Disease! I was really inspired by Chad’s lecture on the protocell and membranes, as well as our ISS by Taren Ginter on primordial membranes. From that, I found Dr. Rheinstädter’s research on membrane biophysics, and it spiralled from there! I really loved the combination of math, physics, and biology, especially when combined for membrane biophysics.

    Thanks for reading my post,
    Emily Martin

  7. Nica Dimaandal Avatar
    Nica Dimaandal

    Hi Emily!

    The title is so clever and it was really interesting to read about this possible factor for Alzheimer’s Disease. I could really see your passion through this post! Just a few comments:

    – P1: I am having trouble understanding the connection between protein amyloid-β and peptide Aβ.
    – Figure 1 and P2: Could you expand on what thermodynamic favourability is? Since Cross Beta Sheet is also labelled in the figure, could you explain this as well?
    – P2S3: I am also having trouble understanding what a large aggregation and small aggregation exactly is. Maybe a figure could help visualize this sentence as well (if space allows!)

    Again, a very well informative post! I just feel some expansions can help with the overall understanding of the undergrad audience (at least for the first years)!

    Happy editing!!
    Nica

  8. Hala El-Barghouthi Avatar
    Hala El-Barghouthi

    Hi Emily! Ioved reading your blog post, amazing job at explaining the approach so seamlessly!!

    A few suggestions I have:
    In P3S4: “Unfortunately, curcumin has a low bioavailability,” you should remove a and writing “curcumin has low bioavailability.”
    In P3S5: you say such as twice in the same sentence, try cutting that out by replacing the second one with including or breaking it into two sentences for less repetetiveness.

    Overall, amazing blog post and amazing writing style!!
    Happy editing!!
    -Hala

Leave a Reply